Lysoway Therapeutics vs Oryon Cell Therapies
Lysoway Therapeutics vs Oryon Cell Therapies, compared side by side on 11 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Lysoway Therapeutics is on 48/100 and Oryon Cell Therapies on 62/100.
Where each one leads
Lysoway Therapeutics
- funding raised: $45.0M against $21.0M
Oryon Cell Therapies
- our overall score: 62/100 against 48/100
At a glance
| Measure | Lysoway Therapeutics | Oryon Cell Therapies |
|---|---|---|
| What it is | Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. | Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience | Biotechnology, Health, Neuroscience, Cell Therapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2021 | Not published |
| Headquarters | Cambridge, USA | Belmont, USA |
| Status | Inactive | Inactive |
Size, funding and growth
| Measure | Lysoway Therapeutics | Oryon Cell Therapies |
|---|---|---|
| Total funding | $45.0M | $21.0M |
| Latest round | Series A | Series A |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 1,282 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Lysoway Therapeutics | Oryon Cell Therapies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 62/100 |
| Traction | 38/100 | 38/100 |
| Community | 15/100 | Not published |
| Search visibility | 20/100 | 19/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (22/100) |
Lysoway Therapeutics vs Oryon Cell Therapies: common questions
Which is better, Lysoway Therapeutics or Oryon Cell Therapies?
On our 0-100 score Oryon Cell Therapies rates higher (62/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 11 data points above: read the rows that match what you are buying for.
How do Lysoway Therapeutics and Oryon Cell Therapies compare on the numbers?
Lysoway Therapeutics leads on funding raised ($45.0M against $21.0M). Oryon Cell Therapies leads on our overall score (62/100 against 48/100).
Read the full Lysoway Therapeutics review and pricing or the Oryon Cell Therapies review and pricing. You can also browse other Lysoway Therapeutics alternatives we track.